Literature DB >> 2643102

Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells.

R G Goodwin1, S Lupton, A Schmierer, K J Hjerrild, R Jerzy, W Clevenger, S Gillis, D Cosman, A E Namen.   

Abstract

A cDNA encoding biologically active human interleukin 7 was isolated by hybridization with the homologous murine clone. Nucleotide sequence analysis indicated that this cDNA was capable of encoding a protein of 177 amino acids with a signal sequence of 25 amino acids and a calculated mass of 17.4 kDa for the mature protein. Recombinant human interleukin 7 stimulated the proliferation of murine pre-B cells and was active on cells harvested from human bone marrow that are enriched for B-lineage progenitor cells. Analysis of RNA by blot hybridization demonstrated the presence of two size classes of interleukin 7 mRNA in human splenic and thymic tissue.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2643102      PMCID: PMC286452          DOI: 10.1073/pnas.86.1.302

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Screening lambdagt recombinant clones by hybridization to single plaques in situ.

Authors:  W D Benton; R W Davis
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

2.  Early production of intracellular IgM by B-lymphocyte precursors in mouse.

Authors:  M C Raff; M Megson; J J Owen; M D Cooper
Journal:  Nature       Date:  1976-01-22       Impact factor: 49.962

3.  A simple and very efficient method for generating cDNA libraries.

Authors:  U Gubler; B J Hoffman
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

4.  Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli.

Authors:  D Pennica; W E Holmes; W J Kohr; R N Harkins; G A Vehar; C A Ward; W F Bennett; E Yelverton; P H Seeburg; H L Heyneker; D V Goeddel; D Collen
Journal:  Nature       Date:  1983-01-20       Impact factor: 49.962

5.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

6.  Antigens displayed on murine B lymphocyte precursors.

Authors:  P W Kincade; G Lee; T Watanabe; L Sun; M P Scheid
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

7.  The isolation and characterization of linked delta- and beta-globin genes from a cloned library of human DNA.

Authors:  R M Lawn; E F Fritsch; R C Parker; G Blake; T Maniatis
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

8.  Mouse pre-B cells synthesize and secrete mu heavy chains but not light chains.

Authors:  D Levitt; M D Cooper
Journal:  Cell       Date:  1980-03       Impact factor: 41.582

9.  B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes.

Authors:  L M Nadler; K C Anderson; G Marti; M Bates; E Park; J F Daley; S F Schlossman
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

10.  A monoclonal antibody that recognizes B cells and B cell precursors in mice.

Authors:  R L Coffman; I L Weissman
Journal:  J Exp Med       Date:  1981-02-01       Impact factor: 14.307

View more
  77 in total

1.  The serum factor from patients with ulcerative colitis that induces T cell proliferation in the mouse thymus is interleukin-7.

Authors:  M Watanabe; N Watanabe; Y Iwao; H Ogata; T Kanai; Y Ueno; M Tsuchiya; H Ishii; S Aiso; S Habu; T Hibi
Journal:  J Clin Immunol       Date:  1997-07       Impact factor: 8.317

2.  Interleukin-7 in the skin of Schistosoma mansoni-infected mice is associated with a decrease in interferon-gamma production and leads to an aggravation of the disease.

Authors:  I Wolowczuk; M Delacre; O Roye; S L Giannini; C Auriault
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

3.  Apoptosis and interleukin 7 gene expression in chronic B-lymphocytic leukemia cells.

Authors:  B W Long; P L Witte; G N Abraham; S A Gregory; J M Plate
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

4.  A human recombinant IL-7/HGFβ hybrid cytokine enhances antitumor immunity in mice.

Authors:  Feng Han; Rong Hu; Min Su; Yanni Yu; Hua Yang; Laijun Lai
Journal:  Am J Cancer Res       Date:  2017-08-01       Impact factor: 6.166

5.  Membrane microdomains and cytoskeleton organization shape and regulate the IL-7 receptor signalosome in human CD4 T-cells.

Authors:  Blanche Tamarit; Florence Bugault; Anne-Hélène Pillet; Vincent Lavergne; Pascal Bochet; Nathalie Garin; Ulf Schwarz; Jacques Thèze; Thierry Rose
Journal:  J Biol Chem       Date:  2013-01-17       Impact factor: 5.157

6.  IL-7 Dependence in human B lymphopoiesis increases during progression of ontogeny from cord blood to bone marrow.

Authors:  Yasmin Khan Parrish; Ineavely Baez; Terry-Ann Milford; Abigail Benitez; Nicholas Galloway; Jaqueline Willeman Rogerio; Eva Sahakian; Mercy Kagoda; Grace Huang; Qian-Lin Hao; Yazmar Sevilla; Lora W Barsky; Ewa Zielinska; Mary A Price; Nathan R Wall; Sinisa Dovat; Kimberly J Payne
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

7.  Structural and biophysical studies of the human IL-7/IL-7Ralpha complex.

Authors:  Craig A McElroy; Julie A Dohm; Scott T R Walsh
Journal:  Structure       Date:  2009-01-14       Impact factor: 5.006

8.  Stimulation of B-cell lymphopoiesis by interleukin-7 leads to aggravation of murine leishmaniasis.

Authors:  A Gessner; A Will; M Vieth; K Schröppel; M Röllinghoff
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

9.  Immunological effects of insulin-like growth factor-I--enhancement of immunoglobulin synthesis.

Authors:  K Robbins; S McCabe; T Scheiner; J Strasser; R Clark; P Jardieu
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

10.  Antitumor effects of interleukin-7 and adoptive immunotherapy on human colon carcinoma xenografts.

Authors:  W J Murphy; T C Back; K C Conlon; K L Komschlies; J R Ortaldo; T J Sayers; R H Wiltrout; D L Longo
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.